Invention Grant
![Substituted pyrrolo[2,3-d]pyrimidines as JAK inhibitors](/docs/US/2022-10-04/US11459333B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrrolo[2,3-d]pyrimidines as JAK inhibitors
-
Application No.: US16988253Application Date: 2020-08-07
-
Publication No.: US11459333B2Publication Date: 2022-10-04
- Inventor: Raju Mohan , John Nuss , Jason Harris , Shendong Yuan
- Applicant: Vimalan Biosciences, Inc.
- Applicant Address: US CA Encinitas
- Assignee: Vimalan Biosciences, Inc.
- Current Assignee: Vimalan Biosciences, Inc.
- Current Assignee Address: US CA Encinitas
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D487/04
![Substituted pyrrolo[2,3-d]pyrimidines as JAK inhibitors](/abs-image/US/2022/10/04/US11459333B2/abs.jpg.150x150.jpg)
Abstract:
Described herein are Janus kinase (JAK) inhibitors of the Formula (I′): and methods of utilizing JAK inhibitors of the Formula (I′) in the treatment of diseases, disorders, or conditions. Also described herein are pharmaceutical compositions containing such compounds.
Public/Granted literature
- US20210040100A1 JAK INHIBITORS Public/Granted day:2021-02-11
Information query
IPC分类:
